Asthma in Children and Adolescents: A Comprehensive Approach to Diagnosis and Management

被引:31
作者
Chang, Christopher [1 ]
机构
[1] Thomas Jefferson Univ, Div Allergy Asthma & Immunol, Nemours Childrens Hosp, Wilmington, DE 19803 USA
关键词
Asthma; Allergies; Exercise-induced asthma; Pediatric asthma; Atopic march; Wheezing; Viral respiratory infections; EXHALED NITRIC-OXIDE; EOSINOPHILIC CATIONIC PROTEIN; DOG-DANDER EXTRACTS; EXERCISE-INDUCED BRONCHOCONSTRICTION; SUBLINGUAL ALLERGOID IMMUNOTHERAPY; PLATELET-ACTIVATING-FACTOR; DOUBLE-BLIND; AIRWAY INFLAMMATION; GENE POLYMORPHISMS; CAT-DANDER;
D O I
10.1007/s12016-011-8261-3
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Asthma is a chronic disease that has a significant impact on quality of life and is particularly important in children and adolescents, in part due to the higher incidence of allergies in children. The incidence of asthma has increased dramatically during this time period, with the highest increases in the urban areas of developed countries. It seems that the incidence in developing countries may follow this trend as well. While our knowledge of the pathophysiology of asthma and the available of newer, safer medication have both improved, the mortality of the disease has undergone an overall increase in the past 30 years. Asthma treatment goals in children include decreasing mortality and improving quality of life. Specific treatment goals include but are not limited to decreasing inflammation, improving lung function, decreasing clinical symptoms, reducing hospital stays and emergency department visits, reducing work or school absences, and reducing the need for rescue medications. Non-pharmacological management strategies include allergen avoidance, environmental evaluation for allergens and irritants, patient education, allergy testing, regular monitoring of lung function, and the use of asthma management plans, asthma control tests, peak flow meters, and asthma diaries. Achieving asthma treatment goals reduces direct and indirect costs of asthma and is economically cost-effective. Treatment in children presents unique challenges in diagnosis and management. Challenges in diagnosis include consideration of other diseases such as viral respiratory illnesses or vocal cord dysfunction. Challenges in management include evaluation of the child's ability to use inhalers and peak flow meters and the management of exercise-induced asthma.
引用
收藏
页码:98 / 137
页数:40
相关论文
共 167 条
  • [1] CLINICAL-APPLICATION OF EOSINOPHILIC CATIONIC PROTEIN IN ASTHMA
    AHLSTEDT, S
    [J]. ALLERGY PROCEEDINGS, 1995, 16 (02): : 59 - 62
  • [2] A METAANALYSIS OF THE EFFECT OF ORAL AND INHALED CORTICOSTEROIDS ON GROWTH
    ALLEN, DB
    MULLEN, ML
    MULLEN, B
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1994, 93 (06) : 967 - 976
  • [3] Chloride transport and the actions of nedocromil sodium and cromolyn sodium in asthma
    Alton, EWFW
    Norris, AA
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1996, 98 (05) : S102 - S105
  • [4] Antoniu SA, 2010, CURR OPIN MOL THER, V12, P233
  • [5] Role of tumor necrosis factor alpha in asthma
    Babu, KS
    Davies, DE
    Holgate, ST
    [J]. IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA, 2004, 24 (04) : 583 - +
  • [6] BALFOUR-LYNN L, 1987, Pediatrician, V14, P237
  • [7] GROWTH AND CHILDHOOD ASTHMA
    BALFOURLYNN, L
    [J]. ARCHIVES OF DISEASE IN CHILDHOOD, 1986, 61 (11) : 1049 - 1055
  • [8] Corticosteroids decrease exhaled nitric oxide in children with acute asthma
    Baraldi, E
    Azzolin, NM
    Zanconato, S
    Dario, C
    Zacchello, F
    [J]. JOURNAL OF PEDIATRICS, 1997, 131 (03) : 381 - 385
  • [9] A CALCIUM-ANTAGONIST, NIFEDIPINE, MODIFIES EXERCISE-INDUCED ASTHMA
    BARNES, PJ
    WILSON, NM
    BROWN, MJ
    [J]. THORAX, 1981, 36 (10) : 726 - 730
  • [10] Exhaled nitric oxide, susceptibility and new-onset asthma in the Children's Health Study
    Bastain, T. M.
    Islam, T.
    Berhane, K. T.
    McConnell, R. S.
    Rappaport, E. B.
    Salam, M. T.
    Linn, W. S.
    Avol, E. L.
    Zhang, Y.
    Gilliland, F. D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2011, 37 (03) : 523 - 531